Your browser doesn't support javascript.
loading
Autosomal dominant early onset Alzheimer's disease in the Mexican state of Jalisco: High frequency of the mutation PSEN1 c.1292C>A and phenotypic profile of patients.
Dumois-Petersen, Sofia; Gallegos-Arreola, Martha P; Magaña-Torres, María T; Perea-Díaz, Francisco J; Ringman, John M; Figuera, Luis E.
Afiliación
  • Dumois-Petersen S; División de Genética, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara, Jalisco, Mexico.
  • Gallegos-Arreola MP; Doctorado en Genética Humana, CUCS-UdeG, Guadalajara, Jalisco, Mexico.
  • Magaña-Torres MT; División de Genética, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara, Jalisco, Mexico.
  • Perea-Díaz FJ; División de Genética, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara, Jalisco, Mexico.
  • Ringman JM; División de Genética, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara, Jalisco, Mexico.
  • Figuera LE; Department of Neurology, Keck School of Medicine at USC, Los Angeles, California, USA.
Am J Med Genet C Semin Med Genet ; 184(4): 1023-1029, 2020 12.
Article en En | MEDLINE | ID: mdl-33274538
ABSTRACT
Mutations in three genes (APP, PSEN1, and PSEN2) are the main cause of the autosomal dominant early-onset Alzheimer's disease (AD-EOAD). In PSEN1, the A431E (c.1292C>A, rs63750083) mutation is suspected to have exerted a founder effect in the State of Jalisco, Mexico. In Guadalajara, Jalisco, Mexico, this mutation was found in 46 index cases evaluated for AD-EOAD. In our genealogical analysis, 301 affected relatives of the mutation carriers were identified, 195 of whom were already deceased at the time of interview. Moreover, 560 descendants had a 50% risk of carrying the mutation, and 348 were potentially at risk. A systematic phenotyping was performed in 39 patients. The mean onset age was 42.5 ± 3.9 years, and no significant difference in onset age was observed between the male and female patients. Furthermore, a substantial clinical heterogeneity and high frequencies of spastic paraparesis, language disorders, and neuropsychiatric symptoms were observed. To our knowledge, the investigated families represent the second biggest population carrying a PSEN1 mutation in Latin America, offering a unique opportunity to study the genetic basis of Alzheimer's disease. Addressing AD-EOAD warrants an integral approach involving a deep understanding of its clinical behavior, as well as counseling protocols and prevention studies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Precursor de Proteína beta-Amiloide / Enfermedad de Alzheimer Tipo de estudio: Guideline Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Mexico Idioma: En Revista: Am J Med Genet C Semin Med Genet Asunto de la revista: GENETICA MEDICA Año: 2020 Tipo del documento: Article País de afiliación: México

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Precursor de Proteína beta-Amiloide / Enfermedad de Alzheimer Tipo de estudio: Guideline Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Mexico Idioma: En Revista: Am J Med Genet C Semin Med Genet Asunto de la revista: GENETICA MEDICA Año: 2020 Tipo del documento: Article País de afiliación: México